Shapelets: Possibilities and limitations of shape‐based virtual screening

Complementarity of molecular surfaces is crucial for molecular recognition. A method for representation of molecular shape is presented. We decompose the molecular surface into commensurate patches with defined shape by fitting hyperbolical paraboloids onto a triangulated isosurface of the Gaussian model of a molecule. As a result of this decomposition we obtain a 3D graph representation of the molecular shape, which can be used for complete and partial shape matching and isosteric group searching. To point out the possibilities and limitations of shape‐only models, we challenged our method by three scenarios in a virtual screening contest: rigid body alignment, consensus shape filtering, and target‐specific screening. © 2007 Wiley Periodicals, Inc. J Comput Chem, 2008

[1]  H M Holden,et al.  The binding of L-valyl-L-tryptophan to crystalline thermolysin illustrates the mode of interaction of a product of peptide hydrolysis. , 1989, The Journal of biological chemistry.

[2]  R. Kurumbail,et al.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.

[3]  Gisbert Schneider,et al.  Collection of bioactive reference compounds for focused library design , 2003 .

[4]  Veerabahu Shanmugasundaram,et al.  Virtual screening: are we there yet? , 2006, Mini reviews in medicinal chemistry.

[5]  David A. Cosgrove,et al.  A novel method of aligning molecules by local surface shape similarity , 2000, J. Comput. Aided Mol. Des..

[6]  Wolfgang Heiden,et al.  Topological analysis of complex molecular surfaces , 1992 .

[7]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[8]  B. Matthews,et al.  Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases. , 1984, Biochemistry.

[9]  Gustavo A. Arteca,et al.  Molecular Shape Descriptors , 2007 .

[10]  Egon L. Willighagen,et al.  The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..

[11]  W G Hol,et al.  Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs. , 2000, Journal of molecular biology.

[12]  Jeffrey D. Ullman,et al.  Introduction to Automata Theory, Languages and Computation , 1979 .

[13]  J. A. Grant,et al.  A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.

[14]  Petra Schneider,et al.  Comparison of correlation vector methods for ligand-based similarity searching , 2003, J. Comput. Aided Mol. Des..

[15]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[16]  Peter Willett,et al.  Graph-Theoretic Techniques for Macromolecular Docking , 2000, J. Chem. Inf. Comput. Sci..

[17]  Jin Li,et al.  On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors , 2006, J. Chem. Inf. Model..

[18]  Christian Hofbauer,et al.  SURFCOMP: A Novel Graph-Based Approach to Molecular Surface Comparison , 2004, J. Chem. Inf. Model..

[19]  J. Kraut,et al.  Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. , 1990, Biochemistry.

[20]  H M Holden,et al.  Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond. , 1987, Science.

[21]  Matthias Keil,et al.  Pattern recognition strategies for molecular surfaces. I. Pattern generation using fuzzy set theory , 2002, J. Comput. Chem..

[22]  William E. Lorensen,et al.  Decimation of triangle meshes , 1992, SIGGRAPH.

[23]  C. Bron,et al.  Algorithm 457: finding all cliques of an undirected graph , 1973 .

[24]  James F. Blinn,et al.  A Generalization of Algebraic Surface Drawing , 1982, TOGS.

[25]  A. Spada,et al.  Crystal structures of human factor Xa complexed with potent inhibitors. , 2000, Journal of medicinal chemistry.

[26]  D. R. Holland,et al.  Inhibition of thermolysin and neutral endopeptidase 24.11 by a novel glutaramide derivative: X-ray structure determination of the thermolysin-inhibitor complex. , 1994, Biochemistry.

[27]  A. Olson,et al.  Shape analysis of molecular surfaces , 1993, Biopolymers.

[28]  Daniel L Cheney,et al.  Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. , 2002, Bioorganic & medicinal chemistry letters.

[29]  B. Matthews,et al.  Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis. , 1982, Biochemistry.

[30]  W RuiterdeG.C.,et al.  Shape in chemistry: An introduction to molecular shape and topology , 1995 .

[31]  Huafeng Xu,et al.  Retrospect and prospect of virtual screening in drug discovery. , 2002, Current topics in medicinal chemistry.

[32]  Ruth Nussinov,et al.  Efficient Unbound Docking of Rigid Molecules , 2002, WABI.

[33]  D E Tronrud,et al.  Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin. , 1989, European journal of biochemistry.

[34]  Sung-Hou Kim,et al.  Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa. , 2000, Biochemistry.

[35]  William E. Lorensen,et al.  Marching cubes: A high resolution 3D surface construction algorithm , 1987, SIGGRAPH.

[36]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[37]  J. A. Grant,et al.  A Gaussian Description of Molecular Shape , 1995 .

[38]  Brian K. Shoichet,et al.  Molecular docking using shape descriptors , 1992 .

[39]  W. Kabsch A solution for the best rotation to relate two sets of vectors , 1976 .

[40]  H M Holden,et al.  Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. , 1989, Biochemistry.